ACSS2	Acyl-CoA synthetase short-chain family member 2
AhR	Aryl hydrocarbon receptor
APCs	Antigen-presenting cells
ARG1	Arginase 1
CART-T	Chimeric antigen receptor T Cell
CBM588	Clostridium butyricum MIYAIRI 588
CCL20	C-C motif chemokine ligand 20
CRC	Colorectal cancer
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
DCs	Dendritic cells
FFAR2	Free fatty acid receptor 2
FFAR3	Free fatty acid receptor 3
FMT	Faecal microbiota transplantation
Gαq	G protein subunit alpha q
HCC	Hepatocellular carcinoma
HDAC	Histone deacetylase
ICIs	Immune checkpoint inhibitors
ID2	Inhibitor of DNA binding 2
IFN-γ	Interferon gamma
IGF1	Insulin-like growth factor 1
IL	Interleukin
JAK1/2	Janus kinase 1/2
LBPs	Live biotherapeutic products
LPS	Lipopolysaccharide
MAMPs	Microbe-associated molecular patterns
MAPK	Mitogen-activated protein kinase
MART-1	Melanoma antigen recognised by T cells 1
MDSCs	Myeloid-derived suppressor cells
MHC	Major histocompatibility complex
MSI-H	Microsatellite instability-high
mTOR	Mechanistic target of rapamycin
NF-κB	Nuclear factor kappa B
NK	Natural Killer
NSCLC	Non-small cell lung cancer
OS	Overall survival
PD-1	Programmed cell death protein 1
PD-L1	Programmed death-ligand 1
PFS	Progression-free survival
PI3K	Phosphoinositide 3-kinase
PPARγ	Peroxisome proliferator-activated receptor gamma
PRRs	Pattern recognition receptors
RCC	Renal cell carcinoma
SCFAs	Short-chain fatty acids
TKI	Tyrosine kinase inhibitor
TLR3	Toll-like receptor 3
TLR4	Toll-like receptor 4
TLR5	Toll-like receptor 5
TME	Tumour microenvironment
TNF-α	Tumour necrosis factor alpha
TRAMP	Transgenic adenocarcinoma of the mouse prostate
Tregs	Regulatory T cells